Meena Asmar
University of Southern Denmark(DK)Frederiksberg Hospital(DK)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Diabetes Management and Research, Adipose Tissue and Metabolism, Diabetes and associated disorders
Most-Cited Works
- → The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action(2010)272 cited
- → An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future(2011)199 cited
- → Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans(2010)168 cited
- → ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating β1 integrin function(2003)162 cited
- → The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor(2017)124 cited
- → ADAM12/Syndecan-4 Signaling Promotes β1Integrin-dependent Cell Spreading through Protein Kinase Cα and RhoA(2003)114 cited
- → Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes Mellitus(2009)101 cited
- → Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men(2015)92 cited
- → On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans(2009)81 cited
- → Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances(2010)60 cited